Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;37(3):e14699.
doi: 10.1111/ctr.14699. Epub 2022 May 23.

Combining donor derived cell free DNA and gene expression profiling for non-invasive surveillance after heart transplantation

Erik J Henricksen  1 , Yasbanoo Moayedi  2 , Saira Purewal  3 , Julien Valverde Twiggs  4 , Kian Waddell  4 , Helen Luikart  4 , Jiho Han  5 , Kent Feng  5 , Brian Wayda  4 , Roy Lee  1 , Yasuhiro Shudo  6 , Shirin Jimenez  4 , Kiran K Khush  4 , Jeffrey J Teuteberg  4
Affiliations

Combining donor derived cell free DNA and gene expression profiling for non-invasive surveillance after heart transplantation

Erik J Henricksen et al. Clin Transplant. 2023 Mar.

Abstract

Background: Donor-derived cell free DNA (dd-cfDNA) and gene expression profiling (GEP) offer noninvasive alternatives to rejection surveillance after heart transplantation; however, there is little evidence on the paired use of GEP and dd-cfDNA for rejection surveillance.

Methods: A single center, retrospective analysis of adult heart transplant recipients. A GEP cohort, transplanted from January 1, 2015 through December 31, 2017 and eligible for rejection surveillance with GEP was compared to a paired testing cohort, transplanted July 1, 2018 through June 30, 2020, with surveillance from both dd-cfDNA and GEP. The primary outcomes were survival and rejection-free survival at 1 year post-transplant.

Results: In total 159 patients were included, 95 in the GEP and 64 in the paired testing group. There were no differences in baseline characteristics, except for less use of induction in the paired testing group (65.6%) compared to the GEP group (98.9%), P < .01. At 1-year, there were no differences between the paired testing and GEP groups in survival (98.4% vs. 94.7%, P = .23) or rejection-free survival (81.3% vs. 73.7% P = .28).

Conclusions: Compared to post-transplant rejection surveillance with GEP alone, pairing dd-cfDNA and GEP testing was associated with similar survival and rejection-free survival at 1 year while requiring significantly fewer biopsies.

Keywords: biomarker; dysfunction; graft survival; heart (allograft) function; rejection.

PubMed Disclaimer

References

REFERENCES

    1. Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match. J Heart Lung Transplant. 2019; 38(10): 1056-1066.
    1. Khush KK. Clinical utility of donor-derived cell-free DNA testing in cardiac transplantation. J Heart Lung Transplant. 2021; 40(6): 397-404.
    1. Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. New Engl J Med. 2010; 362(20): 1890-1900.
    1. Kanwar MK, Khush KK, Pinney S, et al. Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients. J Heart Lung Transpl. 2021; 40(2): 101-107.
    1. Moayedi Y, Gomez CA, Fan CPS, et al. Infectious complications after heart transplantation in patients screened with gene expression profiling. J Heart Lung Transpl. 2019; 38(6): 611-618.

Substances

LinkOut - more resources